Header Logo

Connection

HASHEM EL-SERAG to Case-Control Studies

Back to Details
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Case-Control Studies.
HASHEM EL-SERAG
Connection Strength
2.908
Case-Control Studies
  1. Barrett's esophagus-associated genetic loci in African Americans: a case-control study using the All of Us Research Program. Eur J Gastroenterol Hepatol. 2026 Jun 01; 38(6):684-690.
    View in: PubMed
    Score: 0.143
  2. Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma. Eur J Gastroenterol Hepatol. 2023 12 01; 35(12):1349-1353.
    View in: PubMed
    Score: 0.122
  3. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018 12; 155(6):1828-1837.e2.
    View in: PubMed
    Score: 0.086
  4. Factors That Contribute to Indeterminate Results From the?QuantiFERON-TB Gold In-Tube Test in Patients With?Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018 10; 16(10):1616-1621.e1.
    View in: PubMed
    Score: 0.081
  5. External Validation of the Michigan Barrett's Esophagus Prediction Tool. Clin Gastroenterol Hepatol. 2017 07; 15(7):1124-1126.
    View in: PubMed
    Score: 0.077
  6. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study. Gastroenterology. 2015 Nov; 149(6):1392-8.
    View in: PubMed
    Score: 0.069
  7. Metabolic syndrome and the risk of Barrett's oesophagus in white males. Aliment Pharmacol Ther. 2015 Jun; 41(11):1182-9.
    View in: PubMed
    Score: 0.067
  8. Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking. Dig Dis Sci. 2015 Jan; 60(1):65-73.
    View in: PubMed
    Score: 0.065
  9. Statin use is associated with a decreased risk of Barrett's esophagus. Gastroenterology. 2014 Aug; 147(2):314-23.
    View in: PubMed
    Score: 0.063
  10. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1832-9.e6.
    View in: PubMed
    Score: 0.063
  11. Brief report: the length of newly diagnosed Barrett's esophagus may be decreasing. Dis Esophagus. 2015 Jul; 28(5):418-21.
    View in: PubMed
    Score: 0.063
  12. Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus. 2015 Apr; 28(3):283-90.
    View in: PubMed
    Score: 0.063
  13. A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71.
    View in: PubMed
    Score: 0.062
  14. No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus. Dig Dis Sci. 2014 Jan; 59(1):108-16.
    View in: PubMed
    Score: 0.061
  15. Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus. Aliment Pharmacol Ther. 2013 Oct; 38(7):817-24.
    View in: PubMed
    Score: 0.060
  16. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):229-238.e3.
    View in: PubMed
    Score: 0.060
  17. Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83.
    View in: PubMed
    Score: 0.060
  18. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
    View in: PubMed
    Score: 0.059
  19. Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control. 2013 May; 24(5):1005-14.
    View in: PubMed
    Score: 0.058
  20. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9.
    View in: PubMed
    Score: 0.058
  21. Occupational exposure and the risk of Barrett's esophagus: a case-control study. Dig Dis Sci. 2013 Jul; 58(7):1967-75.
    View in: PubMed
    Score: 0.058
  22. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1.
    View in: PubMed
    Score: 0.058
  23. Human papillomavirus and the risk of Barrett's esophagus. Dis Esophagus. 2013 Jul; 26(5):517-21.
    View in: PubMed
    Score: 0.056
  24. Expression of androgen receptors in Barrett esophagus. J Clin Gastroenterol. 2012 Mar; 46(3):251-2.
    View in: PubMed
    Score: 0.055
  25. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2012 Mar; 55(3):759-68.
    View in: PubMed
    Score: 0.054
  26. Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Dig Dis Sci. 2010 Dec; 55(12):3404-7.
    View in: PubMed
    Score: 0.048
  27. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010 Jun; 138(7):2260-6.
    View in: PubMed
    Score: 0.047
  28. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8.
    View in: PubMed
    Score: 0.045
  29. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus. 2009; 22(7):571-87.
    View in: PubMed
    Score: 0.044
  30. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009 May; 136(5):1601-8.
    View in: PubMed
    Score: 0.044
  31. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008 Nov; 49(5):831-44.
    View in: PubMed
    Score: 0.043
  32. Genetic association studies: from "searching under the lamppost" to "fishing in the pond". Gastroenterology. 2008 Mar; 134(3):662-4.
    View in: PubMed
    Score: 0.041
  33. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol. 2008 Feb 15; 167(4):377-89.
    View in: PubMed
    Score: 0.041
  34. Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2007 Jun; 5(6):696-701.
    View in: PubMed
    Score: 0.039
  35. Oral contraception and the risk of hepatocellular carcinoma. J Hepatol. 2007 Oct; 47(4):506-13.
    View in: PubMed
    Score: 0.039
  36. The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc. 2006 Nov; 64(5):671-5.
    View in: PubMed
    Score: 0.038
  37. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005 Oct; 100(10):2151-6.
    View in: PubMed
    Score: 0.035
  38. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol. 2005 May; 100(5):1002-8.
    View in: PubMed
    Score: 0.034
  39. Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol. 2005 Feb; 3(2):175-83.
    View in: PubMed
    Score: 0.033
  40. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology. 2024 07 01; 80(1):87-101.
    View in: PubMed
    Score: 0.031
  41. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol. 2003 Jan; 98(1):167-74.
    View in: PubMed
    Score: 0.029
  42. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002 Dec; 36(6):1439-45.
    View in: PubMed
    Score: 0.029
  43. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002 Aug; 123(2):476-82.
    View in: PubMed
    Score: 0.028
  44. Diabetes increases the risk of acute hepatic failure. Gastroenterology. 2002 Jun; 122(7):1822-8.
    View in: PubMed
    Score: 0.028
  45. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology. 2001 Dec; 121(6):1294-9.
    View in: PubMed
    Score: 0.027
  46. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 2001 Aug; 96(8):2462-7.
    View in: PubMed
    Score: 0.026
  47. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001 Jul; 96(7):2013-8.
    View in: PubMed
    Score: 0.026
  48. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol. 2001 Jul; 96(7):2206-10.
    View in: PubMed
    Score: 0.026
  49. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 06; 14(6):667-674.
    View in: PubMed
    Score: 0.025
  50. Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610.
    View in: PubMed
    Score: 0.024
  51. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020 03; 115(3):381-387.
    View in: PubMed
    Score: 0.024
  52. Outcome of erosive reflux esophagitis after Nissen fundoplication. Am J Gastroenterol. 1999 Jul; 94(7):1771-6.
    View in: PubMed
    Score: 0.023
  53. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prev Res (Phila). 2019 04; 12(4):237-246.
    View in: PubMed
    Score: 0.022
  54. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans. Aliment Pharmacol Ther. 2018 08; 48(4):469-477.
    View in: PubMed
    Score: 0.021
  55. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med. 2018 05; 7(5):2180-2191.
    View in: PubMed
    Score: 0.021
  56. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997 Sep; 113(3):755-60.
    View in: PubMed
    Score: 0.020
  57. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer. 2017 04 01; 140(7):1693-1699.
    View in: PubMed
    Score: 0.019
  58. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
    View in: PubMed
    Score: 0.019
  59. Inverse Association Between Gluteofemoral Obesity and Risk of?Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3.
    View in: PubMed
    Score: 0.018
  60. Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci. 2016 Apr; 61(4):1139-47.
    View in: PubMed
    Score: 0.018
  61. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29.
    View in: PubMed
    Score: 0.017
  62. Physical activity and the risk of Barrett's esophagus. Dis Esophagus. 2016 Apr; 29(3):248-54.
    View in: PubMed
    Score: 0.017
  63. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol. 2014 Mar; 48(3):218-23.
    View in: PubMed
    Score: 0.016
  64. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.015
  65. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013 Aug; 108(8):1314-21.
    View in: PubMed
    Score: 0.015
  66. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol. 2007 May; 102(5):1016-21.
    View in: PubMed
    Score: 0.010
  67. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005 Mar; 128(3):620-6.
    View in: PubMed
    Score: 0.008
  68. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001 Aug; 33(2):123-6.
    View in: PubMed
    Score: 0.007
  69. Celiac sprue among US military veterans: associated disorders and clinical manifestations. Dig Dis Sci. 1999 May; 44(5):966-72.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.